Accueil | Fils de syndication
Medscape HIV AIDS - Objets Actus
|
Intracranial Hemorrhage Unlikely With Tipranavir for HIV
Perjantai, Joulukuu 05, 2008 - 10:15 - 1 kuukausi depuis - Presse spécialisée - Medscape HIV AIDS Although use of the protease inhibitor tipranavir by patients with HIV might prompt an increase in the risk of intracranial hemorrhage, such events are rare, researchers report in the November 1st issue of Clinical Infectious Diseases. Reuters Health Information |
|
Better Care, Better Bottom Line for Hospitals
Perjantai, Joulukuu 05, 2008 - 06:40 - 1 kuukausi depuis - Presse spécialisée - Medscape HIV AIDS R. Sean Morrison, MD, Prof. of Geriatrics and Medicine at Mount Sinai School of Medicine and Director of the National Palliative Care Research Center, discusses an economic reason for palliative care. The Medscape Journal of Medicine |
|
Oxidative Stress and HIV Infection: Target Pathways for Novel Therapies?
Torstai, Joulukuu 04, 2008 - 03:43 - 1 kuukausi depuis - Presse spécialisée - Medscape HIV AIDS Oxidative stress may contribute to several aspects of HIV disease, including viral replication, inflammatory response and decreased immune cell proliferation. Future HIV Therapy |
|
American College of Physicians Recommends Routine Screening for HIV
Torstai, Joulukuu 04, 2008 - 03:00 - 1 kuukausi depuis - Presse spécialisée - Medscape HIV AIDS The American College of Physicians has issued a statement that clinicians should routinely screen all patients for HIV. Medscape Medical News |
|
HIV Protease Inhibitors Active Against Leishmania Species
Torstai, Joulukuu 04, 2008 - 11:00 - 1 kuukausi depuis - Presse spécialisée - Medscape HIV AIDS In vitro studies show that the intracellular survival of Leishmania species that cause the opportunistic disease visceral leishmaniasis is significantly reduced by HIV-1 protease inhibitors, Canadian and Indian researchers report in the November issue of Clinical Infectious Diseases. Reuters Health Information |
|
Managing Drug-Drug Interaction Risks
Tiistai, Joulukuu 02, 2008 - 10:00 - 1 kuukausi depuis - Presse spécialisée - Medscape HIV AIDS This case-based activity identifies risk factors for drug-drug interactions and presents management tools to help anticipate and prevent associated adverse events for your patients. Medscape Pharmacists |
|
ICAAC/IDSA 2008: Antiretroviral Therapy Clinical Trials
Tiistai, Joulukuu 02, 2008 - 10:00 - 1 kuukausi depuis - Presse spécialisée - Medscape HIV AIDS Dr. Mark Wainberg reviews presentations from the 2008 combined ICAAC/IDSA meetings on antiretroviral therapy and Dr. John G. Bartlett answers Medscape's questions on treatment of the naive patient. Medscape HIV/AIDS |
|
48th ICAAC/46th IDSA Annual Meetings: HIV Clinical Trials in Naive Patients -- An Expert Interview With John G. Bartlett, MD
Tiistai, Joulukuu 02, 2008 - 09:50 - 1 kuukausi depuis - Presse spécialisée - Medscape HIV AIDS Dr. John G. Bartlett answers questions concerning presentations at the 2008 combined ICAAC/IDSA meetings (October 25-28, 2008; Washington, DC). Medscape HIV/AIDS |
|
48th ICAAC/46th IDSA Annual Meetings: Update on Antiretroviral Therapy
Tiistai, Joulukuu 02, 2008 - 09:50 - 1 kuukausi depuis - Presse spécialisée - Medscape HIV AIDS Dr. Mark A. Wainberg highlights the important presentations from the 2008 combined ICAAC/IDSA meetings (October 25-28, 2008; Washington, DC) that dealt with advances in antiretroviral therapy. Medscape HIV/AIDS |
|
Radiotherapy Safe for Prostate Cancer in HIV-Infected Patients
Tiistai, Joulukuu 02, 2008 - 09:38 - 1 kuukausi depuis - Presse spécialisée - Medscape HIV AIDS The results of small study suggest that radiotherapy can be safely used to treat prostate cancer in HIV-infected men, having no long-term effect on CD4+ cell count or viral load. Reuters Health Information |
1 – 2 – 3 – 4 – 5 – 6 – 7 – 8 – 9 – 10 – 11 – 12 – 13 – 14 – 15 – 16 – 17 – 18 – 19 – 20 >
Actus fournies par : Medscape HIV/AIDS Headlines
